Çelebi Bekir, Bakkaloğlu Zekiye, Ünaldı Özlem, Karagöz Alper, Kılıç Selçuk, Durmaz Rıza
Ministry of Health, General Directorate of Public Health, Department of Zoonotic and Vector-borne Diseases, Ankara, Turkey.
Ministry of Health, General Directorate of Public Health, Department of Microbiology Reference Laboratory, Ankara, Turkey.
Mikrobiyol Bul. 2020 Jan;54(1):1-10. doi: 10.5578/mb.68784.
Francisella tularensis is a gram-negative, coccobasillus, facultative intracellular bacteria and causes a zoonotic disease, tularemia in humans. F.tularensis has four subspecies, which have different virulences for humans as F.tularensis subsp. tularensis, F.tularensis subsp. holarctica, F.tularensis subsp. mediasiatica and F.tularensis subsp. novicida. F.tularensis subsp. tularensis is the most virulent subspecies and mortality rate is high in human cases. F.tularensis subsp. holarctica, which has been reported in our country to date, has lower virulence than that of subsp. tularensis, and causes rare lethality among untreated patients. According to the erythromycin resistance and the properties of glucose-glycerol fermentation, F.tularensis subsp. holarctica has three biovar as biovar I, biovar II and biovar japonica. F.tularensis subsp. mediasiatica has been reported only in a few central asian countries and its virulence is similar to the F.tularensis subsp. holarctica F.tularensis subsp. novicida is avirulent for immunocompetent individuals but has been observed to cause infection in immunocompromised individuals. The aim of this study was to determine the F.tularensis subspecies in 259 F.tularensis strains isolated from clinical specimens, drinking water and a rodent sample and 517 F.tularensis PCR-positive DNA isolated from clinical specimens between years 2009 and 2014. Conventional PCR was performed using primers specific for the RD1 (Region Difference) region of F.tularensis. Subspecies were differentiated depending on the difference in PCR amplification product size. In our study, F.tularensis subsp. holarctica was detected in 764 samples yielding 922 base pair (bp) amplification product. The DNA samples obtained from one water and 11 lymph aspirates were determined as F.tularensis subsp. holarctica biovar japonica. The DNA sequence analysis of the amplification product of the RD1 region of the isolate from water sample was determined. The 1136 bp nucleotide sequence obtained from the DNA sequence analysis was 100% similar to F.tularensis subsp. holarctica biovar japonica (FCS075 strain-accesion number AF469618) when compared with GenBank data. The whole genome sequence of this isolate was also determined and recorded to GenBank with accesion number CP007148. None of the samples used in our study belonged to other sub-species. F.tularensis subsp. holarctica biovar japonica positive 11 lymph aspirate samples were sent to our center from Ankara (n= 1), Kayseri (n= 1) and Afyon (n= 9) provinces. The results of the current study revealed that F.tularensis subsp. holarctica biovar japonica caused a tularemia outbreak in a village in Afyon province at first time and it was observed sporadically in two other different provinces.
土拉弗朗西斯菌是一种革兰氏阴性、球杆菌、兼性胞内细菌,可引起人畜共患疾病——人类兔热病。土拉弗朗西斯菌有四个亚种,对人类的毒力各不相同,分别为土拉弗朗西斯菌土拉亚种、土拉弗朗西斯菌全北区亚种、土拉弗朗西斯菌中亚细亚亚种和土拉弗朗西斯菌新凶手亚种。土拉弗朗西斯菌土拉亚种是毒力最强的亚种,人类感染病例的死亡率很高。我国迄今报道的土拉弗朗西斯菌全北区亚种,其毒力低于土拉亚种,在未经治疗的患者中致死率很低。根据对红霉素的耐药性以及葡萄糖 - 甘油发酵特性,土拉弗朗西斯菌全北区亚种有三个生物变种,即生物变种I、生物变种II和日本生物变种。土拉弗朗西斯菌中亚细亚亚种仅在少数中亚国家有报道,其毒力与土拉弗朗西斯菌全北区亚种相似。土拉弗朗西斯菌新凶手亚种对免疫功能正常的个体无致病性,但在免疫功能低下的个体中可引起感染。本研究的目的是确定从临床标本、饮用水和一份啮齿动物样本中分离出的259株土拉弗朗西斯菌菌株,以及2009年至2014年间从临床标本中分离出的517份土拉弗朗西斯菌PCR阳性DNA中的土拉弗朗西斯菌亚种。使用针对土拉弗朗西斯菌RD1(区域差异)区域的特异性引物进行常规PCR。根据PCR扩增产物大小的差异区分亚种。在我们的研究中,在764个样本中检测到土拉弗朗西斯菌全北区亚种,产生922碱基对(bp)的扩增产物。从一份水样和11份淋巴抽吸物中获得的DNA样本被确定为土拉弗朗西斯菌全北区亚种日本生物变种。对水样分离株的RD1区域扩增产物进行了DNA序列分析。与GenBank数据相比,从DNA序列分析中获得的1136 bp核苷酸序列与土拉弗朗西斯菌全北区亚种日本生物变种(FCS075菌株,登录号AF469618)100%相似。该分离株的全基因组序列也已确定并以登录号CP007148记录到GenBank。我们研究中使用的样本均不属于其他亚种。11份土拉弗朗西斯菌全北区亚种日本生物变种阳性的淋巴抽吸物样本分别从安卡拉(n = 1)、开塞利(n = 1)和阿菲永(n = 9)省送至我们中心。本研究结果表明,土拉弗朗西斯菌全北区亚种日本生物变种首次在阿菲永省的一个村庄引起兔热病暴发,在另外两个不同省份呈散发性出现。